LAMTOR1 and metabolic dysfunction-associated steatohepatitis: These results illustrate the important role of <i>LAMTOR1</i> in the progression of NASH and malignant transformation of liver inflammation, which provides a theoretical basis for the diagnosis and treatment of NASH or possible NASH-driven HCC.